254 related articles for article (PubMed ID: 26989293)
21. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
22. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.
Zhang C; Wang C; Chen X; Yang C; Li K; Wang J; Dai J; Hu Z; Zhou X; Chen L; Zhang Y; Li Y; Qiu H; Xing J; Liang Z; Ren B; Yang C; Zen K; Zhang CY
Clin Chem; 2010 Dec; 56(12):1871-9. PubMed ID: 20943850
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
[No Abstract] [Full Text] [Related]
25. MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkers.
Wang Y; Zhang J; Zhao W; Wang D; Ma W; Shang S; Feng C; Yu H
Mol Med Rep; 2017 Jun; 15(6):3833-3839. PubMed ID: 28440443
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
27. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma.
Hirajima S; Komatsu S; Ichikawa D; Takeshita H; Konishi H; Shiozaki A; Morimura R; Tsujiura M; Nagata H; Kawaguchi T; Arita T; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2013 May; 108(9):1822-9. PubMed ID: 23579215
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
30. Different expression of miRNAs in early esophageal squamous cell carcinoma with differential prognosis.
Lu J; Lu N; Xue L; Jin M
Dis Esophagus; 2015; 28(4):386-93. PubMed ID: 24697845
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
[TBL] [Abstract][Full Text] [Related]
32. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
Bulibu J; Wang W; Tang Y; Li N; Saifuding K
Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
[TBL] [Abstract][Full Text] [Related]
33. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
34. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
Xu H; Yao Y; Meng F; Qian X; Jiang X; Li X; Gao Z; Gao L
Medicine (Baltimore); 2015 Nov; 94(44):e1558. PubMed ID: 26554762
[TBL] [Abstract][Full Text] [Related]
35. [Serum miRNAs as new biomarkers for esophageal squamous cell carcinoma].
Li YY; Liu ZG; Wang L; Yuan YY; Liu P; Wang LS
Yi Chuan; 2015 Apr; 37(4):315-320. PubMed ID: 25881696
[TBL] [Abstract][Full Text] [Related]
36. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
37. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma.
Dong W; Li B; Wang J; Song Y; Zhang Z; Fu C; Zhang P
Oncol Rep; 2016 Mar; 35(3):1449-56. PubMed ID: 26708917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
